The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease.

Raj, Desh; Tomar, Bhawna; Lahiri, Amit; Mulay, Shrikant R

Raj, Desh; Tomar, Bhawna; Lahiri, Amit; Mulay, Shrikant R.

Afiliação

Raj D; Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi, 110001, India.
Tomar B; Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India.
Lahiri A; Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi, 110001, India.
Mulay SR; Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow, 226031, India; Academy of Scientific and Innovative Research (AcSIR), New Delhi, 110001, India. Electronic address: shrikant.mulay@cdri.res.in.

Pharmacol Res ; 152: 104617, 2020 02.

Article em En | MEDLINE | ID: mdl-31881272

Assuntos

Fígado Gorduroso/complicações; Microbioma Gastrointestinal; Intestinos; Rim; Fígado; Insuficiência Renal Crônica/etiologia; Animais; Fígado Gorduroso/microbiologia; Humanos; Insuficiência Renal Crônica/microbiologia

Palavras-chave

CKD; Fibrosis; Gut microbiota; Gut-kidney axis; Gut-liver axis; Inflammation; Insulin resistance; Intestinal barrier integrity; Liver-kidney axis; NAFLD; NASH

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Renal Crônica / Fígado Gorduroso / Microbioma Gastrointestinal / Intestinos / Rim / Fígado Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google